ScoreComparison
Why is ADMA Biologics, Inc. ?
1
Company has a low Debt to Equity ratio (avg) at times
2
Healthy long term growth as Net Sales has grown by an annual rate of 64.71%
3
With a growth in Operating Profit of 60.05%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 17 consecutive quarters
- INTEREST COVERAGE RATIO(Q) Highest at 3,166.39
- RAW MATERIAL COST(Y) Fallen by -13.43% (YoY)
- NET SALES(Q) Highest at USD 134.22 MM
4
With ROE of 49.48%, it has a very expensive valuation with a 8.75 Price to Book Value
- Over the past year, while the stock has generated a return of -31.36%, its profits have risen by 126.2% ; the PEG ratio of the company is 0.1
5
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 2.65% over the previous quarter.
6
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 16.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -31.36% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to ADMA Biologics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is ADMA Biologics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
ADMA Biologics, Inc.
-44.24%
0.59
50.23%
S&P 500
13.68%
0.84
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
64.71%
EBIT Growth (5y)
38.02%
EBIT to Interest (avg)
0.77
Debt to EBITDA (avg)
0.83
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.97
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.78%
ROE (avg)
14.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
8.75
EV to EBIT
22.66
EV to EBITDA
21.63
EV to Capital Employed
8.53
EV to Sales
7.75
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
37.66%
ROE (Latest)
49.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
INTEREST COVERAGE RATIO(Q)
Highest at 3,166.39
RAW MATERIAL COST(Y)
Fallen by -13.43% (YoY
NET SALES(Q)
Highest at USD 134.22 MM
OPERATING PROFIT(Q)
Highest at USD 53.04 MM
OPERATING PROFIT MARGIN(Q)
Highest at 39.51 %
PRE-TAX PROFIT(Q)
Highest at USD 49.69 MM
-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.2 times
Here's what is working for ADMA Biologics, Inc.
Interest Coverage Ratio
Highest at 3,166.39 and Grown
In each period in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
Highest at USD 134.22 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 53.04 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 39.51 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 49.69 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Raw Material Cost
Fallen by -13.43% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ADMA Biologics, Inc.
Debtors Turnover Ratio
Lowest at 5.2 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
